Oct 6 (Reuters) - Goldman Sachs Group Inc GS.N:
MAPLIGHT THERAPEUTICS INC - INITIAL PUBLIC OFFERING PRICE IS $17.00 PER SHARE
MAPLIGHT THERAPEUTICS INC SEES IPO OF 14.75 MILLION SHARES OF COMMON STOCK - SEC FILING
MAPLIGHT THERAPEUTICS - AFFILIATES OF GOLDMAN SACHS & CO. LLC ARE EXPECTED TO PURCHASE 476,707 SHARES OF COMMON STOCK IN CONCURRENT PRIVATE PLACEMENT
MAPLIGHT THERAPEUTICS - ACCOUNTS ADVISED BY T. ROWE PRICE INVESTMENT MANAGEMENT INDICATED INTEREST IN PURCHASING UP TO $40 MILLION IN SHARES AT IPO PRICE
Source text: [ID:n0001193125-25-231829]
Further company coverage: GS.N
((Reuters.Briefs@thomsonreuters.com;))